EUCTR2020-005542-42-SE进行中（未招募）1 期
Intrathecal contrast-enhanced MRI for investigation of cerebrospinal fluid transportation - 2020/11 Intrathecal MRI-contrast
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients investigated for suspected idiopathic normal pressure hydrocephalus at Umeå University Hospital
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 60
排除标准
- •Known contradicting allergies
- •Known contraindications for magnetic resonance imaging
- •Renal impairment (as deffined by blood test at admission)
- •Current treatment with anticoagulation medication
- •Low threshold to seizures
- •History of bronchial asthma
- •Previous investigation with gadolinium contrast medium
- •Mini Mental State Examination (MMSE) <18
- •Not able to understand instructions needed for informed concent.
研究者
相似试验
招募中
不适用
Evaluation of constrast enhanced MRI for therapeutic decisions in acute stroke with follow-up MRII63Cerebral infarctionDRKS00005197niversitätsklinikum Freiburg100
已完成
不适用
Contrast enhanced Magnetic Resonance Imaging of the lungs in children with Cystic Fibrosis.10038716mucoviscoidosisNL-OMON31207Erasmus MC, Universitair Medisch Centrum Rotterdam30
进行中（未招募）
1 期
Dynamic contrast enhanced MRI (DCE-MRI) assessment of the vascular changes induced with bevacizumab alone and in combination with interferon-a in patients with advanced renal cell carcinoma. - DCE-MRI changes in tumour vaculature with Bevacizumab and Interferon in advanced RCCPreviously untreated metastatic (stage IV) or locally advanced (inoperable stage III), renal cell carcinomaMedDRA version: 9.1Level: HLTClassification code 10038408Term: Renal cell carcinomasEUCTR2008-006414-19-GBEast and North Hertfordhsire NHS Trust30
已完成
不适用
Borderzone SamplingHigh Grade GliomaGlioblastomaNCT00780819Maastricht University Medical Center10
已完成
不适用
DCE-MRI for Assessment of Response to TACE of HCCCarcinoma, HepatocellularNCT02878109Centre hospitalier de l'Université de Montréal (CHUM)40